H, M., AS, B., K, C., M, G., D, G., E, H., . . . A, S. (2026). Selective serotonin reuptake inhibitor use during pregnancy and maternal depression-a nationwide birth cohort study on risks to the mother and the newborn. American journal of obstetrics & gynecology MFM, 8(4), 101910. https://doi.org/10.1016/j.ajogmf.2026.101910
Chicago Style (17th ed.) CitationH, Malm, et al. "Selective Serotonin Reuptake Inhibitor Use During Pregnancy and Maternal Depression-a Nationwide Birth Cohort Study on Risks to the Mother and the Newborn." American Journal of Obstetrics & Gynecology MFM 8, no. 4 (2026): 101910. https://doi.org/10.1016/j.ajogmf.2026.101910.
MLA (9th ed.) CitationH, Malm, et al. "Selective Serotonin Reuptake Inhibitor Use During Pregnancy and Maternal Depression-a Nationwide Birth Cohort Study on Risks to the Mother and the Newborn." American Journal of Obstetrics & Gynecology MFM, vol. 8, no. 4, 2026, p. 101910, https://doi.org/10.1016/j.ajogmf.2026.101910.